M. el Gamil

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.

S. Rosenberg, P. Robbins, Y. Kawakami, 1995, Journal of immunology.